Veeva Systems Inc. (0LO3.L)
| Previous close | 188.91 |
| Open | 188.19 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 186.89 - 192.87 |
| 52-week range | 160.60 - 234.73 |
| Volume | |
| Avg. volume | 1,201 |
| Market cap | 27.938B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 0.76 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing in pre-launch scientific activities and prioritizing congresses gain 40% faster treatment adoption than those that invested less. Early-career experts are also more open to digital engagement and four times more likely to start patients on a new treatment.
- PR Newswire
Vita Global Sciences Partners with Veeva to Streamline Clinical Data Management
Veeva Systems (NYSE: VEEV) today announced that Vita Global Sciences is partnering with Veeva to modernize its clinical data management processes and improve collaboration with key trial stakeholders. With Veeva Vault EDC, the CRO is establishing a foundation for study efficiency and faster study builds.
- PR Newswire
Tigermed Advances Clinical Data Management with Veeva Vault EDC
Veeva Systems (NYSE: VEEV) today announced that Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed") has selected Veeva Vault EDC as its technology foundation for modern electronic data capture (EDC). With Vault EDC, Tigermed can simplify complex data management for faster study builds and mid-study amendments with zero downtime. The improvements can significantly advance Tigermed's clinical data management for the benefit of its customers and the industry.
